VISCERAL PAIN TREATMENT MARKET ANALYSIS

Visceral Pain Treatment MarketSize and Trends

The global visceral pain treatment market is estimated to be valued at US$ 14.4 Billion in 2023 and is expected to exhibit a CAGR of 5.7% during the forecast period (2023-2030).

Figure 1. Global Visceral Pain Treatment Market Share (%), By Type, 2023

Market Trends

Increasing new strategies to treat visceral pain is expected to drive the global visceral pain treatment market growth over the forecast period. For instance, on July 16, 2021, Multidisciplinary Digital Publishing Institute, based in Switzerland explained that the use of tetrodotoxin (TTX) is a deadly neurotoxin produced by bacteria such as Shewanella putrefaciens., and it is a selective sodium Na+ channel blocker that has generated considerable interest in recent years. TTX is ingested by pufferfish, different marine bivalves and gastropods, and the trophic chain is thought to be the main source of its accumulation. Before the toxin had been identified, fugu fish were used in traditional Japanese medicine to cure neuralgia in leprosy patients. Subsequently, TTX was discovered, extracted, and purified and used to dampen spasms in patients with tetanus. This toxin dramatically dampens the firing of abdominal pain by specifically blocking the voltage-gated sodium channels pore, thereby disrupting the passage of Na+. As such, TTX has been proposed as a possible strategy to manage pain by blocking voltage-gated sodium channels.